Today, many Canadians celebrate Holi, the Festival of Colours.
OTTAWA, ON, March 28, 2021 /CNW/ - Today, Hindu communities in Canada and around the world celebrate Holi. Also known as the Festival of Colours, this important festival marks the arrival of spring.
Holi is a time of reflection, optimism, and hope for the coming year?a time to celebrate the hope that the renewal of the seasons brings. Traditionally, bonfires light up this festival as people sing, dance, share food, and sprinkle each other with bright colours. As we continue our fight against the COVID-19 pandemic, celebrations will take place in accordance with local public health guidelines, yet I have no doubt that they will be just as colourful and vibrant.
With its message of peace and friendship, Holi is one of the most celebrated festivals in South Asia and in many countries around the world. Let us take time to recognize and celebrate the important contributions of Hindu communities in Canada to all aspects of society.
As Minister of Diversity and Inclusion and Youth, I wish everyone celebrating Holi a very joyous festival. Keep well and safe. Holi Hai!
Allied Market Research published a report, titled, "Pet Insurance Market by Policy Coverage (Accident Only, Accident and Illness, and Others), Animal Type (Dogs, Cats, and Others), and Sales Channel (Agency, Broker, and Others): Global...
Bradda Head Lithium Ltd (AIM:BHL), the North America-focused lithium development group, is pleased to announce that it has come to a settlement regarding the fraudulent payment first notified on 29 March 2022 and subsequently disclosed in the audited...
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...
